ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000598.1|Polytheonamides_2 # 464 # 2200 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.610	BGC0000598.1|Polytheonamides_2 	464	2200	-	Loose	1250	30.4166	mecA	30.77	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGAGCCAATCCAATAGAATGGGTACGACGCCAGCGGACGCCACTGAAGCCGGTACCGACTCCAGTGCCGCTCCCGCCGGGGACGCTTCTGCGGATCAAGAGGTGGCTCCTGGCTGGGTTGCCGTTTTGTTTCCCAACGGCGAGCCGCTCGTCTATGCATTGTCGATTGCCGATGAGCGCTATGCGACGCAGTGGACCGTGTACCGGGGGCCACGCGAGGGTGATCTCCACGAGATTGAATTCTTCCTTGAGCTTGATCCGGTGGCGATGGGTCTAGGGGGAGAACTTGTGAGGCAACGCAGCGTCTTGCTCTGCAACGGCGCACTCGATCCCGTGCACTACCTCAGCGAGGCAGGTGGTACTCGCTGGGAGGTCCGCTTTGAATCGGCCGAGGTGACGGCCACGCTTCCCGATGGATCGGAGCAAGTCGTGCCGCGCGGGGAGGCGCAGTTCATCGCCGCCGACAATGTGCCGGGGCACAAGGCACTGATCTTTGCCGCCTTGGCATGCCGCAAGCTCCTCGACCAAGAGGTGACAGTTGGACTCTTTCTCGCCAATCAGCTGGCGGCCGTTCCCTACCAGATGAGTCCCGCACTCGACCTTGCCGCCGAGTCCGGCACGTGGCACCGCTCCTCGCATCTTGAAGAGATTCACCTCGATGAACACGGGTTGATGATCGAAGGCATGGTGCCGACGCAAGGGGTCCGCGGATGGCTGGAGCGCCCTGGTCCGCCAGTGCCGCAATGGCTTGACGAGGATCAGCCGGTCACCGTCCCGCTCCGCTACCACTATCGCGACAATACCCGCTTCCGTCTTGAGGACGTCACTATCCCCGGCCCGGTGACGCCAATCGGTGCGACGCTCTCCATTCCGGAAGGTCCGGGCCCCTTCCCAGCCGTGCTCTTCCTGAGTGGTTCGGGCACTCATGATCGTCACGGGATCGCGGGTGAAATAGATATGGGAACGCACGAAATTATGGACTTTTTGGCGGAGCAAGGCCTTCTGGGGTTGCGTTTCGATTCCCGCGGGGCGGGCACGACGAAAATGGGCGAGGACACTCTGGTTCGCGGCCTCGATTCGGAAATTGCTGATGCCCGGGCATGCCTAGAATTTCTGCGCGCTCGCCCGGAAGCGGCTGGAGGTGCCGTTTTCCTCCTTGGCCATAGCCAGGGCGGCACTGTGGCTCTGGTGCTCGCCGAGCAAGAGGGTATTGCCCTGCGCGGAGTGGTCTTGATGGCCACCATGGGCCGGAGCATCGAGGACGTCATCACCGACCAGATTGTCTACATGGGGAAAGACATCGGCTTGACGGACGAGCAAATCGAGCAGCAGATTCAGGAGGTTCAGGAGGCGGTAGAGTTGGTGAAGGCAGATCATCCGTGGAATCCGGACAATATCCCCCACTACCTCCTCGCGATGTTCCGCAGCCCGACTTGGCTGAAACAGTTATTGTTATACCGGACAGTGGAACTCATTACCCGGCTCCAGTGCCCACTACTCGTGTGTCAGGGTAGCAAAGACTTCCAAGTCTCCGCCGAGCGCGATGCCGAGCTGCTCGTTACCGCAGCTCAAAGTGCGGGCGGTGATTGTACGTATGCGCTCTTCCCCAATCTCGATCACCTCTTCAAGGCGACAGCTGGGGAATCGACAATGGCCCAGTACTTCGATCAAACCCGCCACGTCGATCCGGAGTTCCTCCAGCGCGTCGCAGCCTGGCTGAGCGAACACGCGTCCTGA	MSQSNRMGTTPADATEAGTDSSAAPAGDASADQEVAPGWVAVLFPNGEPLVYALSIADERYATQWTVYRGPREGDLHEIEFFLELDPVAMGLGGELVRQRSVLLCNGALDPVHYLSEAGGTRWEVRFESAEVTATLPDGSEQVVPRGEAQFIAADNVPGHKALIFAALACRKLLDQEVTVGLFLANQLAAVPYQMSPALDLAAESGTWHRSSHLEEIHLDEHGLMIEGMVPTQGVRGWLERPGPPVPQWLDEDQPVTVPLRYHYRDNTRFRLEDVTIPGPVTPIGATLSIPEGPGPFPAVLFLSGSGTHDRHGIAGEIDMGTHEIMDFLAEQGLLGLRFDSRGAGTTKMGEDTLVRGLDSEIADARACLEFLRARPEAAGGAVFLLGHSQGGTVALVLAEQEGIALRGVVLMATMGRSIEDVITDQIVYMGKDIGLTDEQIEQQIQEVQEAVELVKADHPWNPDNIPHYLLAMFRSPTWLKQLLLYRTVELITRLQCPLLVCQGSKDFQVSAERDAELLVTAAQSAGGDCTYALFPNLDHLFKATAGESTMAQYFDQTRHVDPEFLQRVAAWLSEHAS	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	86.53	gnl|BL_ORD_ID|1216|hsp_num:0	1321			1605	1761	methicillin
BGC0000598.1|Polytheonamides_3 # 2389 # 3072 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.547	BGC0000598.1|Polytheonamides_3 	2389	3072	+	Loose	275	28.8758	AAC(6')-Isa	63.16	3002563	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGCGATCAGCTTCAAAGGTGCCCATTTTCCACCCAAAGTCATTTTGATGGGAGTCCGATGGTATCTGGCGTACCCTTTGAGCACGCGCCACGTTGAGGAACTCATGGCAGAACGCGGGGTCCACGTCGATCATTCCACCGTCAACCGCTGGGTGGTGAAGTACAGTCCGCAGCTCGAAGCCGAATTCCACCGGCGCAAACGTGCGGTGTGGACGAGTTGGCGGATGGATGAGACGTACATTAAAGTGAAAGGCGAGTGGAAATACCTCTACCGGGCTGTTGACAAATTCGGCAAGACCATTGATTTTCTGCTCACGGAGCAGCGTGATGAGAAAGCGGCCAGGAAGTTTCTCAACAAGGCGATTGGCCGCCACGGCAGTGTGCCGGAGAAGATCACGATCGATGGTAGTGCGGCCAACGAAGCCGCCATCAAGAGCTACAACAAGGATCACGGCATGTCAATCGAAATTCGCCAGGTCAAGTATCTTAACAACATCGTGGAACAGGATCATCGAGGTGTGAAGCGGATTACGCGGCCGATGCTGGGGTTCCAATCCTTTGACTCCGCTCAGTCCACTCTCACTGGCATCGAGCTGATGCACATGCTGCGAAAAGGGCAGCTTGAAGATAGGGGTGAGCAGGGACTCAGTGTGGCCGATCAGTTCTACGCTCTGGCCTCGTAG	MAISFKGAHFPPKVILMGVRWYLAYPLSTRHVEELMAERGVHVDHSTVNRWVVKYSPQLEAEFHRRKRAVWTSWRMDETYIKVKGEWKYLYRAVDKFGKTIDFLLTEQRDEKAARKFLNKAIGRHGSVPEKITIDGSAANEAAIKSYNKDHGMSIEIRQVKYLNNIVEQDHRGVKRITRPMLGFQSFDSAQSTLTGIELMHMLRKGQLEDRGEQGLSVADQFYALAS	MELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYEETDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYRKVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT	144.59	gnl|BL_ORD_ID|886|hsp_num:0	967			309	366	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000598.1|Polytheonamides_4 # 3316 # 5307 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.593	BGC0000598.1|Polytheonamides_4 	3316	5307	+	Loose	475	30.8018	YEM-1	30.86	3007005	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	YEM beta-lactamase	ATGAGTGATGTGCTTCTAGTCTCGGTACCGTACGCAGCCTTGCAGCACCCATCCCCTGCATTGGGCTGTCTGCAGGCCGTGCTCCGGCGCCGTGGGATCGAAGTCCACACCATGCATGCGAATCTCCGGTTCGCTGAACGGATCGGGATCGGGAACTATACATGGTTCGGTACCTACAGCCGGCCACAGTTGCTCGGCGAGTTGACATTTGCCAAGGCTGCTTTTCCCGACTTCGAGCCCGATCTTCACGCCTATGCCCAGGTCATTAACGTACCGGAAGCGGAACATGCTATCCGCGACGTGCGGCAAGCCGCGGTTTCGTTCATCGACGAGATGGCTCAGCAGATCATCGAGCAAGATCCGAAGATTGTGGGATGTTCCTCAACGTTCCAGCAGAATTGCGCCTCGTTGGCGCTCTTGCGCCGGCTCCGCGAGCTGTCACCGGGCATCGTCACCGTCATGGGTGGAGCAAATTGCGAAAGCGAGATGGGGCGGGCTCTCCATACGAACTTCGACTGGGTAGATTACGTCGTCTCGGGTGATGGGGACGAGGTGTTCCCCGACCTCTGCGAGCGGATTCTTCACAACGACATTGCGGGCATCGCGTCTAACGAGGCGCTGCGCCGTTTCGTATTCACCCCCGCGTCCCGACCGTTCGCTAATTTTCAGGTGGTCGAGCGCGCCACGACTCAGGACATGGACGGATTACCCCTGCCGGACTACGACGATTACTTCCGCGAATTGGCAGAGACAAAAATCGAATACTTTGCGACACCTGGGCTTCTCGTCGAGACCGCGCGCGGTTGCTGGTGGGGGGAAAAACACCCGTGCACTTTTTGCGGCCTCAACGGTGGGTGCATGAGCTTTCGGGCGATGAGCCCGGAGAAGGCGGAGTGGCACATCTGCGAATTGTCCGCCCGCTACGGCATCGACGGGATCGAAGTGATTGATAATATCCTCGCGCCTTCTTATTTTAACACCGTTTTGCCGGCCCTCGCCCGAAAGGAAAAGCGCTTGCGCCTAGCCTGCGAGGTAAAGGCCAACCTGAAGCGGGAGCAAGTGAAAGCGCTGGCGGACGCGGGGGCAATCTGGGTGCAGCCGGGCATCGAGGCCCTGCACGATGAAACGCTTAAGCTCATCGACAAGGGCGCGACGGTCTGCCAGAACCTCCAGTTGCTGAAATGGGCTCGAGAATACGGCGTCCATATTACCTGGAACTATCTACTTGGCATTCCGGGCGAACGGAGGGCGTTATACAAGGAGGTCGCGGACCTCTTGCCCCTCATCATGCATTTACAGGCACCTAATGGACCGGGCTCGCGGCTCAGCTTTGATCGGTTCAGCGTCTATCACACGCATGCAGACCATTATCAGCTCACGTTGCGTCCGGCATGGGGGTATTCGAACGTCTACCCATTGCCGATCAGCCAGCTCATAGATCTGGCCTATCACTTCGACGATGTCGGTCCTAACGCGGTGCTGCGCTCCGATTTTCCGGAAATGGAACTCTTACGAGAGCGTTTGAAGGAATGGTGCGATCTGCAGCCGGAGCCTTCCGGCTATGATGACCCGGCGGATTTGCCTCCCCTCCCCAGGCTAGATGTCTTTGAACGAGACGACGGCAGACTCCTCATCGAAGACACGCGGCCGTGCGCTCCGGCGACGCAGCGCGAGCTCTGTGGGCTCAGCGCCTATCTCTACACCGCGTGCGACCGAGGCCGTACTGCAGCACGGCTTCGGTCCGCTTGTCACGACGAGGGCTTCTCTGAGGCCACTGCGGCCGACGTCGATCGCGAGTTGACACGCCTCATTGACGACAAGCTCATGGCTTTTGTGAGCAACCGGTTTTTGAGCCTCGCTGTGCGGGCGCCATACCCCGCCTGCCGACCCCTGAGTGAACACCCCGACGGGCAGGTGTATCTACGGCCCGTCCAGAAGCACCGCGAGCCGCGCGAGCAGACGATTCAAGACGTATTCGGGCTTAAGCTCTGA	MSDVLLVSVPYAALQHPSPALGCLQAVLRRRGIEVHTMHANLRFAERIGIGNYTWFGTYSRPQLLGELTFAKAAFPDFEPDLHAYAQVINVPEAEHAIRDVRQAAVSFIDEMAQQIIEQDPKIVGCSSTFQQNCASLALLRRLRELSPGIVTVMGGANCESEMGRALHTNFDWVDYVVSGDGDEVFPDLCERILHNDIAGIASNEALRRFVFTPASRPFANFQVVERATTQDMDGLPLPDYDDYFRELAETKIEYFATPGLLVETARGCWWGEKHPCTFCGLNGGCMSFRAMSPEKAEWHICELSARYGIDGIEVIDNILAPSYFNTVLPALARKEKRLRLACEVKANLKREQVKALADAGAIWVQPGIEALHDETLKLIDKGATVCQNLQLLKWAREYGVHITWNYLLGIPGERRALYKEVADLLPLIMHLQAPNGPGSRLSFDRFSVYHTHADHYQLTLRPAWGYSNVYPLPISQLIDLAYHFDDVGPNAVLRSDFPEMELLRERLKEWCDLQPEPSGYDDPADLPPLPRLDVFERDDGRLLIEDTRPCAPATQRELCGLSAYLYTACDRGRTAARLRSACHDEGFSEATAADVDRELTRLIDDKLMAFVSNRFLSLAVRAPYPACRPLSEHPDGQVYLRPVQKHREPREQTIQDVFGLKL	MLKTILQFFVLFTVTQGAYASKIALVKLSDNLYVVEDDYYYRENSMVYIGKDYITVIGATWTPDTAKELDAQIKKISKKPIAEVINTNYHTDRAGGNLYWKSIGAELISTKMTYNLMEKHWQDILETTRKGYDGFPDIPLVLPTKTFDNNFELQNGEIKAIYTGESHTPDGIFVYFPKEKTLYGNCIIKEKLGNLASANIKEYPKTLQKLKNLNLDIKTVVGGHDSPIHGSELIDSYKKLIEAANK	269.51	gnl|BL_ORD_ID|4652|hsp_num:0	5723			237	474	imipenem
BGC0000598.1|Polytheonamides_6 # 7393 # 7830 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.573	BGC0000598.1|Polytheonamides_6 	7393	7830	+	Loose	450	28.4906	HMB-1	35.48	3004092	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	HMB beta-lactamase	ATGGCAGACAGCGACAATACGCCCACATCGAGGAAGGATTTTGAAACTGCGATCATTGCGAAGGCCTGGAAAGATCCGGAATACTTGCGGCGCCTGCGGAGCAATCCGCGTGAAGTGCTGCAGGAAGAACTTGAGGCCCTTCACCCTGGGGCGCAACTCCCCGACGATCTCGGAATCTCGATCCACGAGGAAGATGAAAATCACGTCCATCTGGTCATGCCGCGCCATCCGCAAAACGTGTCAGACCAGACCCTGACAGACGATGACCTCGATCAGGCCGCAGGTGGCACCGGAATCGGCGTTGTGGTGGCCGTGGTCGCCGGTGCCGTCGCCAACACCGGCGCGGGTGTCAATCAGGTCGCAGGTGGCAATATCAATGTGGTGGGGAACATCAACGTCAATGCCAACGTTAGCGTGAATATGAACCAGACCACATAA	MADSDNTPTSRKDFETAIIAKAWKDPEYLRRLRSNPREVLQEELEALHPGAQLPDDLGISIHEEDENHVHLVMPRHPQNVSDQTLTDDDLDQAAGGTGIGVVVAVVAGAVANTGAGVNQVAGGNINVVGNINVNANVSVNMNQTT	MKIHLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVDGKDAYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTNELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPEGLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKKK	60.17	gnl|BL_ORD_ID|4714|hsp_num:0	2753			411	504	
BGC0000598.1|Polytheonamides_7 # 7909 # 9516 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.566	BGC0000598.1|Polytheonamides_7 	7909	9516	+	Loose	1000	28.4906	MCR-7.1	33.33	3004517	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAACCTGCAGTCGATCGACTCTCAGGCAGTTCGTTCGAAGGTGGATGCGGAATACCCGTCGGCTGCGCATGTCAAGCGATTTCTGGAGGTTTGGTGCTCAGGGCTCTATAAGAAAGAAGACTTGCTCACCCGACCGCAGGAAATCCTCGATGCTCACCACGTAGCGATAGATCCGTCCCTCATCTCCGTTCTATTTGAATCGAAATTCTTGCGGGGGAAATCCGGCAAGTTTGACCTGCTACCGCCGCAGTTCGACGCGTTTCGCGACTTTATGATGACGAAGATCCAGTGGCGGCAACAAATCCGCACTGGCTCTGCTCCTGCCGACCCCATATTTCGTGAATTTCGGGAGCGTCAGATCCAGAGATGTGAGATCGAACTCGGCAGCGATCAGAACACCGCCATCGTTCACACGCCCGTCGTGTTCGAGCTGACGCGGGGCTGCTCGGTGAAGTGTTGGTTTTGTGCGCTCGACGCACCGCCTCTCACGGGGATCTTTGACTATTCCCCGGAAAACGCACGATTTTTCCGGGACGTGCTTCGCGTCGTCAAAGACGTGATTGGTCCAGCGAGCAAATGGGCCAGCAGCTACTGGGGAACCGACCCGCTCGACAACCCCGATCAAGAGAAATTTAGCCTTGATTTCCGTGAAATCCTCGGCATGTATCCGCAGACGACGACGGCGATCCCACTGCGCGCGCCCGAGCGCACGCGGAAGTTGCTTGAGGTGTCTCATGCCAGTGGCTGCCTCGTCAACCGCTTCTCGGTTCGTACACCAGCGCAGCTCAGAAAGATTCACGATACGTTTTCGGCAGAGGAGCTGCTCTACACCGAGTTGGTCTTGCAGAATCTGGAATCGGACAGTGTGAAGGCGCGTGCGGGCCGCTTGATCCATTTCGCCGATGATCTCCCCAAACTCGCTGCGAAAGATGAGGAAAAGCTGCTCAATATGCTCCAAGAGCGAGAACCCGAGCTAGCCGCAAAAGCAACGTCGATTCTCATTAATCTCCCAGGCTCCACCGAACCGATCATCAGGGCCACGAGTAACGCCGATGAAGAGGATACCTCCGAGGAATACAATGTGTCCATCAATGTCCCGGGCACTACGTCCTGCCTGACCGGCTTCAAGATCAACATGGTCGATCGCACTGTGGAGCTGTTGAGCCCCTGTCCAGCAAACGAGCGATGGCCGCTCGGACACATTGTGTTTGAGGAAGGGACGTTCGACACAGCCGAAGACCTGAGGACGCTCATGCTCGGCATGATCTCTCGCAATATGGCTGAACGGGTCGTTCCCGAGTCGTTGGTGCGCTTTGTCCCGCGGCTCATCTATCGCGAAGACCCGGAGGGGTTCCGCCTTGGTTCCGTGTTCGGCAACGGTGTGATCTGTCATGACCCGACTCGATCGGCGTACCTCCATCGTCTTGGCAACCTGCTCCGCGAGGGGAAAAAGCGAGCCGGCGAGATCGCGATGCTGTGCTTTTATGAGTTCGGCGTACCTGAAAATTACACGATGGGAAGCATCAACAACATGTTCCATCAGGGCATCATCGCGGAGGAGCCGATCGCCACAGAGGCGCCGATCGCCGTGGCGGCTTACCAGTAA	MNLQSIDSQAVRSKVDAEYPSAAHVKRFLEVWCSGLYKKEDLLTRPQEILDAHHVAIDPSLISVLFESKFLRGKSGKFDLLPPQFDAFRDFMMTKIQWRQQIRTGSAPADPIFREFRERQIQRCEIELGSDQNTAIVHTPVVFELTRGCSVKCWFCALDAPPLTGIFDYSPENARFFRDVLRVVKDVIGPASKWASSYWGTDPLDNPDQEKFSLDFREILGMYPQTTTAIPLRAPERTRKLLEVSHASGCLVNRFSVRTPAQLRKIHDTFSAEELLYTELVLQNLESDSVKARAGRLIHFADDLPKLAAKDEEKLLNMLQEREPELAAKATSILINLPGSTEPIIRATSNADEEDTSEEYNVSINVPGTTSCLTGFKINMVDRTVELLSPCPANERWPLGHIVFEEGTFDTAEDLRTLMLGMISRNMAERVVPESLVRFVPRLIYREDPEGFRLGSVFGNGVICHDPTRSAYLHRLGNLLREGKKRAGEIAMLCFYEFGVPENYTMGSINNMFHQGIIAEEPIATEAPIAVAAYQ	MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVFIPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVLWFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNHRILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARGKNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDEVAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRYTDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ	99.26	gnl|BL_ORD_ID|2678|hsp_num:0	3145			1008	1116	colistin A; colistin B
BGC0000598.1|Polytheonamides_9 # 10693 # 12453 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.621	BGC0000598.1|Polytheonamides_9 	10693	12453	+	Loose	1000	26.5646	MCR-1.14	29.17	3007246	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGATGAGTTCTTCCAGCAGTCGTGAGGGAGACGCCCTCGCCCATGCTGCTGATCCCACAAGGTCAATTGCGGACGACATCACTTGTGGGCTCGACTCGCTAGGCGGCCCTCCCACGGTATGCGATGCTGAACATCCGGTCCCATTTGAGGAGCTATGGCTCGGGTTCGTCGCGCACGCGGCTCGTGCGCTTGAACCGCTCATCGCGCCGTCGTTGCACGCGGCTGTGTTACACGATCCGCACGGACCCCTGCGCTCGCTGCTCATCGAGCTGGCCGAGATGGGCGCGCCAGCGGCTTTCGAGTTGTTTGCACTCTATCGCATCCGGGAGGCGAGTGCCGCGTCCGTCTTCGGAAGTGTCCGCGGGGTAGAGAGTCGAGACACCTATAACGCATTCGTGAAGCACCTCGCCACTCAGCAGCTCTCCCCGCTGTGGGATGCCTTTCCGGCCCTCAAGCCTCTGCTGGCCACCCGTACCAATCTCTTTATAGCCGCCATGGCAGAGTTGTGCCAGCGGTGGGAGGCCGATCACGTAGAGATCATGTCGGTCTTCCCGGAGTTACGAGGGATAGGTGCACCGCAGCGCATTCGCCCCGGCTTATCCGATGCGCATGGCGGTGGGCGAACCGTTACTCGCCTGTCATTCGCCGGTGGTGAGGCGCTTTTCTACAAGCCACGCCCGGTCGACATGGAGTGGGGTTGTGCACAGTTTGTCGAGTGGTTCAACGGCCAAGACCACGGGATGCCGCCGCTCCGGGCGCTTTCGGTCTTGCCCAGAACCGACTATGGCTGGATGGAGGCGGCACGCCCCGCACTGTGCACACATGTTGACGCAGTCGCCCGATTCTACCACCGCGCAGGGATGCTGCTGGCCCTCGCCGACCTTTTCTGCGGGGTCGATTTCCATAGTGAAAACCTGATTGCAAGCGGTGAGTATCCGGTAATCGTGGATCTGGAGACCTTGTTTCATCCGCTGGGGCCTTTCGAATCGCAGGGCGATGCCTTGGAGCGCACAGAGCTGCTGCCACGGCCCATCTACTGTGAAGATGGTGCCCCCTATGTCATCTGCGGGTTAGGTGTGGTTCCTGGAAAGGCGGTCATTGAGCTCCGGCGGCGCGGATGGATCAACATCAATTGCGATAACATGGCGTCCTGTGACGTGACCGTCCCTTGGCCTGTCGGTGGCGCCGTGCCTCGCAACAAAGAGGGTGCGGCGCCGTCGATCGCGACATGGTCGGGCGAGATCGTCTCGGGGTTCTCTGCTATGCATGTGTTCTTCCGCACACGCCGGAACGAGCTGTGGAGCGCCGACGGGCCTATCGTGCAAGCGTTTGGCGGCGGGCGTTCGCGGTTTCTCCTACGCGCGACGCGGATCTATGTGGAGCTACTGCGCCGGGCCGTGCAGCCGCAAGCGCTCGCAGCTCACGCGTCATCGAGCCACATCTTCGATCGTCTGGCGCGCACGGGCCGGGGATGGGATGAGATCCATCGCGTGGAGCGGCAGGCGCTCGATCGCATGGACGTGCCTTATTTCACCATGGAAACCACCGCGCAGTTTGTTCGCGGCGAGGGCCGTACCATCCATGCATTCTTCGCCACGTCCGGGCTTCACATGGCACGGCGCCGGTCGGAGTTCATAGACGATGTCATTCTAAATGACAGGGCCGCGTCGATTCGCAATGTTCTCGAACAATCGAGTTACAGCGGGGAGGCGACCCTACCGGACTCCAGAGTCCAGACCGACGCTGGCGCAGGAGCCTGA	MMSSSSSREGDALAHAADPTRSIADDITCGLDSLGGPPTVCDAEHPVPFEELWLGFVAHAARALEPLIAPSLHAAVLHDPHGPLRSLLIELAEMGAPAAFELFALYRIREASAASVFGSVRGVESRDTYNAFVKHLATQQLSPLWDAFPALKPLLATRTNLFIAAMAELCQRWEADHVEIMSVFPELRGIGAPQRIRPGLSDAHGGGRTVTRLSFAGGEALFYKPRPVDMEWGCAQFVEWFNGQDHGMPPLRALSVLPRTDYGWMEAARPALCTHVDAVARFYHRAGMLLALADLFCGVDFHSENLIASGEYPVIVDLETLFHPLGPFESQGDALERTELLPRPIYCEDGAPYVICGLGVVPGKAVIELRRRGWININCDNMASCDVTVPWPVGGAVPRNKEGAAPSIATWSGEIVSGFSAMHVFFRTRRNELWSADGPIVQAFGGGRSRFLLRATRIYVELLRRAVQPQALAAHASSSHIFDRLARTGRGWDEIHRVERQALDRMDVPYFTMETTAQFVRGEGRTIHAFFATSGLHMARRRSEFIDDVILNDRAASIRNVLEQSSYSGEATLPDSRVQTDAGAGA	MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKVSQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIIPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	108.32	gnl|BL_ORD_ID|4866|hsp_num:0	5851			483	687	colistin A; colistin B
BGC0000598.1|Polytheonamides_10 # 12457 # 12789 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.577	BGC0000598.1|Polytheonamides_10 	12457	12789	+	Loose	1700	24.6386	AxyY	41.67	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATAACGCGACACACCATTTCGAACAGAGCCATTTTGGCACCTTACACGAAGTGGGGCTATACGACGAAGTGAGTATTGAGCTTCTTGAGTACGCTACGGCCGGCTTTAGGTGGGAGATCACTTACGAGTCGCCCGAAGCAGTCGAGGTGATTGATTCCGAATACGTGCCACCGGAAAGTGACGCCGCGGGTGCCGCCGGTCTCCGACGCTTCCGGCTACGGCTGGTTCGCGAAGGACATGTGCGCCTGGCGCTCCAAATGATTTGTCCCTTCCGGAAGGACGATCCACCTGCCGCATCGGGTACGATCGAGCTGCAGGTGCGGCCATAA	MDNATHHFEQSHFGTLHEVGLYDEVSIELLEYATAGFRWEITYESPEAVEVIDSEYVPPESDAAGAAGLRRFRLRLVREGHVRLALQMICPFRKDDPPAASGTIELQVRP	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	10.53	gnl|BL_ORD_ID|2411|hsp_num:0	2799			930	1002	erythromycin; cefepime
